Sakura Sakajiri

Histone deacetylase inhibitors profoundly decrease proliferation of human lymphoid cancer cell lines

Sakura Sakajiri, T. Kumagai, Norihiko Kawamata et al. · Experimental Hematology · 2005 · 150 citations

Life Sciences, Molecular Biology, Oncology +14

Dlk1 in normal and abnormal hematopoiesis

Sakura Sakajiri, James O’Kelly, Dong Yin et al. · Leukemia · 2005 · 116 citations

Medicine, Cell Biology, Hematology +11

DLK1: increased expression in gliomas and associated with oncogenic activities

Dong Yin, Dong Xie, Sakura Sakajiri et al. · Oncogene · 2005 · 88 citations

Medicine, Cancer Biology, Oncology +12

Identification of CD20 C-Terminal Deletion Mutations Associated with Loss of CD20 Expression in Non-Hodgkin's Lymphoma

Yasuhito Terui, Yuji Mishima, Natsuhiko Sugimura et al. · Clinical Cancer Research · 2009 · 73 citations · Full text

Medicine, Hematology, Immunology +17

Safety and pharmacokinetics of milademetan, a MDM2 inhibitor, in Japanese patients with solid tumors: A phase I study

Shunji Takahashi, Yutaka Fujiwara, Kenji Nakano et al. · Cancer Science · 2021 · 72 citations · Full text

Medicine, Oncology, Pharmacology +15